demonstrated that simulated obstructive apnea and hypopnea in patients are associated with an increase in ventricular premature beats and prolongation of ventricular repolarisation, suggesting that negative intrathoracic pressure changes during obstructive apneas may contribute to increased cardiac dysrhythmias in obstructive sleep apnea (OSA). The authors speculate that increased sympathetic activation, which has previously been shown to be present in patients with OSA and during experimentally simulated obstructive apneas, may explain altered arrhythmogenic cardiac electrophysiology during obstructive apneas.
Previously, our group (Linz et al. 2011) showed in a pig model of OSA that forced inspiration against the obstructed upper airways results in substantial negative tracheal pressure (NTP) down to about -60 to -80 cmH 2 O, representing a strong trigger for atrial fibrillation (AF) compared to hypoxia alone. Applied strong NTP causes a pronounced shortening of the atrial effective refractory period and increased susceptibility to AF. Interestingly, NTP-induced atrial effective refractory period shortening was modulated by atropine or atenolol. In addition, the modulation of autonomic nervous system by renal sympathetic denervation displayed pronounced antiarrhythmic effects in the pig model for OSA (Linz et al. 2012) . These findings emphasize the importance of autonomic imbalance in OSA-associated AF. Also, renal sympathetic denervation (RDN) has also been shown to reduce OSA-severity in hypertensive patients as well as blood pressure (Witkowski et al. 2011) .
The first data supportive for potential antiarrhythmic effect of acute RDN in the ventricle have recently been published . These authors reported reduced ventricular tachyarrhythmias in patients with electrical storm and congestive heart failure after renal sympathetic denervation. Whether modulation of the autonomic nervous system is effective in influencing ventricular arrhythmogenic changes in OSA is unknown, and deserves to be tested in experimental and clinical studies.
